This collaborative effort will transform the treatment of children with serious inherited diseases and contribute to the development of exciting new treatment options for a wide range of other diseases, including cancer, across all age groups.
Author Archives: jeansforgenesau
CMRI expands gene therapy research partnership with LogicBio Therapeutics
CMRI is pleased to announce that its partnership with LogicBio Therapeutics to develop the next generation of viral vectors for gene therapy applications has been extended for another two years and two new target tissues.
Australia’s first gene therapy for genetic eye disease
The Therapeutic Goods Administration (TGA) has registered a drug known as LUXTURNA® for the first gene therapy for inherited retinal diseases in Australia. One of our senior scientists, Professor Robyn Jamieson, has been involved in the process to get to this exciting stage.
CMRI – SCHN Formalise Agreement
Decades of past collaborations between CMRI and the SCHN have helped to bridge the gap between biomedical research and clinical application, and we continue to work closely across a number of research areas.